Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer
- DOI
- 10.1186/s13014-026-02902-0
- Published
- 2026-07-31
- Container
- Radiation Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13014-026-02902-0,
title = {Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer},
author = {Lanshan Li and Yuling Hong and Zhenyu Lin and Jianping Zhang and Benhua Xu and Zihan Zhou},
year = {2026},
journal = {Radiation Oncology},
doi = {10.1186/s13014-026-02902-0},
url = {https://doi.org/10.1186/s13014-026-02902-0}
}RIS
TY - JOUR TI - Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer AU - Lanshan Li AU - Yuling Hong AU - Zhenyu Lin AU - Jianping Zhang AU - Benhua Xu AU - Zihan Zhou PY - 2026 JO - Radiation Oncology DO - 10.1186/s13014-026-02902-0 UR - https://doi.org/10.1186/s13014-026-02902-0 ER -
APA
Li, L., Hong, Y., Lin, Z., Zhang, J., Xu, B., & Zhou, Z. (2026). Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer. Radiation Oncology. https://doi.org/10.1186/s13014-026-02902-0
Source records
- crossref · retrieved 2026-11-09T06:04:36.265Z